Medtech company backs down from Pfizer TM oppositions
14-08-2018
mediaphotos / iStockphoto.com
Two trademark oppositions against Pfizer have been suspended as the parties are engaged in negotiations to settle the disputes.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Trademark Trial and Appeal Board, TTAB, trademark opposition, Pfizer, medical technology,
